HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GLUT4 and glycogen synthase are key players in bed rest-induced insulin resistance.

Abstract
To elucidate the molecular mechanisms behind physical inactivity-induced insulin resistance in skeletal muscle, 12 young, healthy male subjects completed 7 days of bed rest with vastus lateralis muscle biopsies obtained before and after. In six of the subjects, muscle biopsies were taken from both legs before and after a 3-h hyperinsulinemic euglycemic clamp performed 3 h after a 45-min, one-legged exercise. Blood samples were obtained from one femoral artery and both femoral veins before and during the clamp. Glucose infusion rate and leg glucose extraction during the clamp were lower after than before bed rest. This bed rest-induced insulin resistance occurred together with reduced muscle GLUT4, hexokinase II, protein kinase B/Akt1, and Akt2 protein level, and a tendency for reduced 3-hydroxyacyl-CoA dehydrogenase activity. The ability of insulin to phosphorylate Akt and activate glycogen synthase (GS) was reduced with normal GS site 3 but abnormal GS site 2+2a phosphorylation after bed rest. Exercise enhanced insulin-stimulated leg glucose extraction both before and after bed rest, which was accompanied by higher GS activity in the prior-exercised leg than the rested leg. The present findings demonstrate that physical inactivity-induced insulin resistance in muscle is associated with lower content/activity of key proteins in glucose transport/phosphorylation and storage.
AuthorsRasmus S Biensø, Stine Ringholm, Kristian Kiilerich, Niels-Jacob Aachmann-Andersen, Rikke Krogh-Madsen, Borja Guerra, Peter Plomgaard, Gerrit van Hall, Jonas T Treebak, Bengt Saltin, Carsten Lundby, Jose A L Calbet, Henriette Pilegaard, Jørgen F P Wojtaszewski
JournalDiabetes (Diabetes) Vol. 61 Issue 5 Pg. 1090-9 (May 2012) ISSN: 1939-327X [Electronic] United States
PMID22403297 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 4-(2-hydroxyphenyl)-1,5-benzodiazepin-2-one
  • Benzodiazepinones
  • Blood Glucose
  • GTPase-Activating Proteins
  • Glucose Transporter Type 4
  • Insulin
  • Palmitates
  • SLC2A4 protein, human
  • TBC1D4 protein, human
  • Glycogen
  • Glycogen Synthase
  • Proto-Oncogene Proteins c-akt
  • Glucose
Topics
  • Bed Rest (adverse effects)
  • Benzodiazepinones
  • Blood Glucose
  • GTPase-Activating Proteins (genetics, metabolism)
  • Gene Expression Regulation (physiology)
  • Glucose (administration & dosage)
  • Glucose Transporter Type 4 (genetics, metabolism)
  • Glycogen (metabolism)
  • Glycogen Synthase (genetics, metabolism)
  • Humans
  • Insulin (metabolism)
  • Insulin Resistance (physiology)
  • Male
  • Muscle, Skeletal (metabolism)
  • Palmitates (metabolism)
  • Phosphorylation
  • Proto-Oncogene Proteins c-akt (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: